A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients

作者：Yu-Jing Liang, Qiuyan Chen, Jing-xiao Xu, Xiufeng Liu, Jian‐Chuan Xia, Li‐Ting Liu, Shanshan Guo, Bin Song, Pan Wang, Jibin Li, Qing Liu, Hao‐Yuan Mo, Ling Guo, Rui Sun, Dong–Hua Luo, Jia He, Yina Liu, Cai-Ping Nie, Lin‐Quan Tang, Jiang Li, Hai‐Qiang Mai · 发表于：European Journal of Cancer · 年份：2023 · DOI：10.1016/j.ejca.2023.112965 · 被引用次数：15 · 研究领域：Cancer Immunotherapy and Biomarkers、Viral-associated cancers and disorders、Head and Neck Cancer Studies